109 results on '"M Woodhall"'
Search Results
2. P.033 Detection of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G (MOG-IgG) by live and fixed cell-based assays
- Author
-
P Kumar, A Cruz, H Sodhi, P Waters, V Victor Mgbachi, M Woodhall, A Mousavi, J Oger, T Aziz, and H Frykman
- Subjects
Neurology ,Neurology (clinical) ,General Medicine - Abstract
Background: MOG-IgG is associated with non-MS demyelinating disease of the optic nerves, spinal cord and brain. Specificity has been issue so we validated the live and fixed MOG-IgG CBAs against the Oxford Autoimmune Neurology Diagnostic Laboratory (OANG) live CBA as a comparator with high specificity. Methods: At BC Neuroimmunology lab (BCNI), 54 MOG-IgG serum samples previously positive by live-CBA at OANG and BCNI were blindly tested by commercial fixed CBA. All 54 MOG IgG positives came from MOG-IgG positive patients. In addition, 256 samples from healthy people and other neurolgic disease were tested. Results: The live MOG-IgG CBA performed at BCNI was 100% concordant (54/54) with OANG live CBA. In contrast, only 49/54 samples were found seropositive by the commercial fixed CBA. The BCNI live-CBA identified 3/256 control samples as positive while 6/256 controls were positive on the fixed commercial CBA. On this cohort the live CBA is 100% sensitive, 98.8% specific and has PPV of 95%. The commercial fixed MOG test is 91% sensitive, 97.6% specific and has PPV of 87.5%. Conclusions: BCNI live MOG-IgG CBAs are in 100% agreement with MOG-IgG. Three positive results in non-MOGAD associated clinical phenotype require further investigation. These data confirm the superiority of the live MOG CBA.
- Published
- 2022
3. Use of geospatial modeling to predict Schistosoma mansoni prevalence in Nyanza Province, Kenya.
- Author
-
Dana M Woodhall, Ryan E Wiegand, Michael Wellman, Elizabeth Matey, Bernard Abudho, Diana M S Karanja, Pauline M N Mwinzi, Susan P Montgomery, and W Evan Secor
- Subjects
Medicine ,Science - Abstract
BACKGROUND: Schistosomiasis, a parasitic disease that affects over 200 million people, can lead to significant morbidity and mortality; distribution of single dose preventative chemotherapy significantly reduces disease burden. Implementation of control programs is dictated by disease prevalence rates, which are determined by costly and labor intensive screening of stool samples. Because ecological and human factors are known to contribute to the focal distribution of schistosomiasis, we sought to determine if specific environmental and geographic factors could be used to accurately predict Schistosoma mansoni prevalence in Nyanza Province, Kenya. METHODOLOGY/PRINCIPAL FINDINGS: A spatial mixed model was fit to assess associations with S. mansoni prevalence in schools. Data on S. mansoni prevalence and GPS location of the school were obtained from 457 primary schools. Environmental and geographic data layers were obtained from publicly available sources. Spatial models were constructed using ArcGIS 10 and R 2.13.0. Lower S.mansoni prevalence was associated with further distance (km) to Lake Victoria, higher day land surface temperature (LST), and higher monthly rainfall totals. Altitude, night LST, human influence index, normalized difference vegetation index, soil pH, soil texture, soil bulk density, soil water capacity, population, and land use variables were not significantly associated with S. mansoni prevalence. CONCLUSIONS: Our model suggests that there are specific environmental and geographic factors that influence S. mansoni prevalence rates in Nyanza Province, Kenya. Validation and use of schistosomiasis prevalence maps will allow control programs to plan and prioritize efficient control campaigns to decrease schistosomiasis burden.
- Published
- 2013
- Full Text
- View/download PDF
4. Assessment of U.S. Pediatrician Knowledge of Toxocariasis
- Author
-
Dana M. Woodhall, LeAnne M. Fox, Craig Shapiro, Amanda P. Garcia, Shequenta L Wray, Kelly K. Stimpert, Andi L. Shane, Chitra S Mani, and Susan P. Montgomery
- Subjects
0301 basic medicine ,Ocular toxocariasis ,Abdominal pain ,Pediatrics ,medicine.medical_specialty ,030231 tropical medicine ,Disease ,Case presentation ,Asymptomatic ,03 medical and health sciences ,Toxocara cati ,0302 clinical medicine ,Zoonoses ,Virology ,medicine ,Animals ,Pediatricians ,Toxocariasis ,biology ,business.industry ,Data Collection ,Articles ,030108 mycology & parasitology ,biology.organism_classification ,medicine.disease ,United States ,Infectious Diseases ,Parasitology ,medicine.symptom ,business ,Toxocara canis - Abstract
Toxocariasis, one of a group of parasitic diseases known as neglected parasitic infections, is a disease caused by the larvae of two species of Toxocara roundworms, Toxocara canis, from dogs, and less commonly Toxocara cati, from cats. Although most infected individuals are asymptomatic, clinical manifestations may include fever, fatigue, coughing, wheezing, or abdominal pain (visceral toxocariasis) or vision loss, retina damage, or eye inflammation (ocular toxocariasis). To assess U.S. pediatrician knowledge of toxocariasis, we conducted an electronic survey of American Academy of Pediatrics members. Of the 2,684 respondents, 1,120 (47%) pediatricians correctly selected toxocariasis as the diagnosis in an unknown case presentation with findings typical for toxocariasis; overall 1,695 (85%) stated they were not confident that their knowledge of toxocariasis was current. This knowledge gap suggests a need for improved toxocariasis awareness and education for U.S. pediatricians, especially those caring for children at risk for infection.
- Published
- 2017
5. Baylisascaris procyonisRoundworm Seroprevalence among Wildlife Rehabilitators, United States and Canada, 2012–2015
- Author
-
Michael J. Yabsley, Lisa N. Rascoe, Dana M. Woodhall, Sukwan Handali, Sarah G H Sapp, Elizabeth B. Gray, Patricia P. Wilkins, Emily W. Lankau, Karen L Bailey, Mark L. Eberhard, and Susan P. Montgomery
- Subjects
Male ,0301 basic medicine ,Veterinary medicine ,Epidemiology ,wildlife rehabilitators ,Baylisascaris procyonis ,Antibodies, Protozoan ,lcsh:Medicine ,Baylisascariasis ,baylisascariasis ,0302 clinical medicine ,Seroepidemiologic Studies ,Zoonoses ,Geography, Medical ,Subclinical infection ,education.field_of_study ,roundworms ,seroprevalence ,biology ,ascarid roundworm ,Dispatch ,030108 mycology & parasitology ,Infectious Diseases ,raccoons ,Female ,Microbiology (medical) ,Canada ,wildlife ,030231 tropical medicine ,Population ,Wildlife ,Zoology ,Animals, Wild ,parasites ,History, 21st Century ,lcsh:Infectious and parasitic diseases ,larva migrans ,03 medical and health sciences ,Baylisascaris procyonis Roundworm Seroprevalence among Wildlife Rehabilitators, United States and Canada, 2012–2015 ,Ascaridoidea ,Animals ,Humans ,Seroprevalence ,lcsh:RC109-216 ,education ,Larva migrans ,occupational illnesses ,lcsh:R ,fungi ,biology.organism_classification ,United States ,Ascaridida Infections ,Immunoglobulin G - Abstract
Baylisascaris procyonis roundworms can cause potentially fatal neural larva migrans in many species, including humans. However, the clinical spectrum of baylisascariasis is not completely understood. We tested 347 asymptomatic adult wildlife rehabilitators for B. procyonis antibodies; 24 were positive, suggesting that subclinical baylisascariasis is occurring among this population.
- Published
- 2016
6. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
- Author
-
J. Rocha, Angela Vincent, Markus Reindl, Patrick Waters, Ichiro Nakashima, Toshiyuki Takahashi, Jacqueline Palace, Douglas Kazutoshi Sato, Maria Isabel Leite, M Woodhall, T. Misu, Bethan Lang, George Tackley, Kazuo Fujihara, Maciej Juryńczyk, and Kevin C. O’Connor
- Subjects
Article ,Myelin oligodendrocyte glycoprotein ,03 medical and health sciences ,0302 clinical medicine ,immune system diseases ,Medicine ,Optic neuritis ,030304 developmental biology ,Alexa Fluor ,0303 health sciences ,Neuromyelitis optica ,biology ,business.industry ,Multiple sclerosis ,hemic and immune systems ,medicine.disease ,Primary and secondary antibodies ,3. Good health ,nervous system diseases ,Neurology ,nervous system ,Acute disseminated encephalomyelitis ,Immunology ,biology.protein ,Neurology (clinical) ,Antibody ,business ,030217 neurology & neurosurgery - Abstract
Objective: To optimize sensitivity and disease specificity of a myelin oligodendrocyte glycoprotein (MOG) antibody assay. Methods: Consecutive sera (n 5 1,109) sent for aquaporin-4 (AQP4) antibody testing were screened for MOG antibodies (Abs) by cell-based assays using either full-length human MOG (FL-MOG) or the short-length form (SL-MOG). The Abs were initially detected by Alexa Fluor goat anti-human IgG (H 1 L) and subsequently by Alexa Fluor mouse antibodies to human IgG1. Results: When tested at 1:20 dilution, 40/1,109 sera were positive for AQP4-Abs, 21 for SLMOG, and 180 for FL-MOG. Only one of the 40 AQP4-Ab–positive sera was positive for SLMOG-Abs, but 10 (25%) were positive for FL-MOG-Abs (p 5 0.0069). Of equal concern, 48% (42/88) of sera from controls (patients with epilepsy) were positive by FL-MOG assay. However, using an IgG1-specific secondary antibody, only 65/1,109 (5.8%) sera were positive on FL-MOG, and AQP4-Ab– positive and control sera were negative. IgM reactivity accounted for the remaining anti-human IgG (H 1 L) positivity toward FL-MOG. The clinical diagnoses were obtained in 33 FL-MOG–positive patients, blinded to the antibody data. IgG1-Abs to FL-MOG were associated with optic neuritis (n 5 11), AQP4-seronegative neuromyelitis optica spectrum disorder (n 5 4), and acute disseminated encephalomyelitis (n 5 1). All 7 patients with probable multiple sclerosis (MS) were MOG-IgG1 negative. Conclusions: The limited disease specificity of FL-MOG-Abs identified using Alexa Fluor goat antihuman IgG (H 1 L) is due in part to detection of IgM-Abs. Use of the FL-MOG and restricting to IgG1-Abs substantially improves specificity for non-MS demyelinating diseases. Classification of evidence: This study provides Class II evidence that the presence of serum IgG1- MOG-Abs in AQP4-Ab–negative patients distinguishes non-MS CNS demyelinating disorders from MS (sensitivity 24%, 95% confidence interval [CI] 9%–45%; specificity 100%, 95% CI 88%–100%). Neurol Neuroimmunol Neuroinflamm 2015;2:e89; doi: 10.1212/ NXI.0000000000000089
- Published
- 2019
7. Solvent Extraction of Copper: An Extractive Metallurgy Exercise for Undergraduate Teaching Laboratories
- Author
-
Jack S. Gavine, Andrew D. Hoyland, Rory P. McCaughan, Iain A. Smellie, Daniel Houston, Liam Wilson, Andrew J. Miller, Leanne Harris, Fiona M. Woodhall, Claire Brodie, and Ross S. Forgan
- Subjects
Aqueous solution ,05 social sciences ,Extraction (chemistry) ,050301 education ,chemistry.chemical_element ,Context (language use) ,General Chemistry ,Extractive metallurgy ,010402 general chemistry ,01 natural sciences ,Copper ,Salicylaldoxime ,0104 chemical sciences ,Education ,chemistry.chemical_compound ,chemistry ,Chemical engineering ,Organic chemistry ,Solvent extraction ,0503 education ,Inorganic Syntheses - Abstract
A multidisciplinary experiment for advanced undergraduate students has been developed in the context of extractive metallurgy. The experiment serves as a model of an important modern industrial process that combines aspects of organic/inorganic synthesis and analysis. Students are tasked to prepare a salicylaldoxime ligand and samples of the corresponding copper and nickel complexes, before performing test extractions and UV–vis spectroscopic analysis. The oxime ligand demonstrates a clear preference for extraction of Cu2+ in the presence of Ni2+ from aqueous solution under the conditions described. It is also possible to demonstrate that the ligand can be recovered and reused. The experiment has successfully been employed in a final year project-based laboratory course involving small groups of students.
- Published
- 2015
8. Epizootiological investigation of a Q fever outbreak and implications for future control strategies
- Author
-
Randall J. Nett, Rachael A. Priestley, Joshua S. Self, Kelly A. Fitzpatrick, Dana M. Woodhall, Alicia D. Anderson, Adam Bjork, Michelle P. Emery, Nicola Marsden-Haug, Tahnee J. Szymanski, Paul H. Kohrs, and Gilbert J. Kersh
- Subjects
Male ,Washington ,medicine.medical_specialty ,Veterinary medicine ,animal diseases ,Q fever ,Abortion ,Polymerase Chain Reaction ,Disease Outbreaks ,law.invention ,Feces ,Oregon ,law ,Zoonoses ,Environmental health ,Epidemiology ,Quarantine ,medicine ,Animals ,Humans ,Serologic Tests ,Goat Diseases ,Montana ,General Veterinary ,business.industry ,Goats ,Public health ,Outbreak ,medicine.disease ,Body Fluids ,Milk ,Vagina ,Herd ,Female ,Q Fever ,business - Abstract
Objective—To describe the epizootiological investigation of an outbreak of Q fever (Coxiella burnetii infection). Design—Epidemiological study. Animals—17 goat herds in Washington, Montana, and Oregon. Procedures—In April 2011, an abortion storm at a commercial goat farm in Washington was determined to be caused by C burnetii. A joint epidemiological investigation by public health and veterinary professionals was subsequently performed to assess the extent of the outbreak by performing a trace-forward of goats sold from the index farm, to determine risk factors associated with infection, and to implement control measures. A herd management plan was developed to control the outbreak and reduce risk of human exposure. Quarantine and temporary holds preventing the sale or movement of goats allowed time for trace-forward investigation, education of farmers regarding disease risk, and testing to determine the scope of the outbreak. Results—17 farms were affected; 21 human Q fever cases were identified. Bacterial shedding in feces, vaginal fluid, or milk was confirmed in 156 of 629 (25%) goats tested by PCR assay. Seroprevalence of antibodies against C burnetii in goats, determined by ELISA, was 12%. The risk for C burnetii infection in goats was highest among females, those on farms associated with human Q fever, and those on Washington farms. A protective effect was observed for goats at farms where the primary form of goat carcass disposal was burial. Conclusions and Clinical Relevance—This outbreak illustrated the importance of a joint investigation for zoonotic pathogens and the need to expand and strengthen relationships between medical, public health, and veterinary partners. Heightened awareness and enhanced veterinary diagnostic capabilities for C burnetii are needed to identify and control outbreaks expediently.
- Published
- 2015
9. Paraneoplastic neurologic disorders in small cell lung carcinoma
- Author
-
M Woodhall, Angela Vincent, Bethan Lang, Paul Gozzard, Paul Maddison, Patrick Waters, Anjan Nibber, and Caroline J. Chapman
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Lung Neoplasms ,medicine.medical_treatment ,GABAB receptor ,Article ,Cohort Studies ,medicine ,Humans ,Prospective Studies ,Prospective cohort study ,Aged ,Chemotherapy ,biology ,business.industry ,Limbic encephalitis ,Middle Aged ,medicine.disease ,Serum samples ,Small Cell Lung Carcinoma ,Cross-Sectional Studies ,HEK293 Cells ,biology.protein ,NMDA receptor ,Female ,Neurology (clinical) ,Antibody ,business ,Follow-Up Studies ,Paraneoplastic Syndromes, Nervous System - Abstract
Objective: To determine the frequency and range of paraneoplastic neurologic disorders (PNDs) and neuronal antibodies in small cell lung carcinoma (SCLC). Methods: Two hundred sixty-four consecutive patients with biopsy-proven SCLC were recruited at the time of tumor diagnosis. All patients underwent full neurologic examination. Serum samples were taken prior to chemotherapy and analyzed for 15 neuronal antibodies. Thirty-eight healthy controls were analyzed in parallel. Results: PNDs were quite prevalent (n = 24, 9.4%), most frequently Lambert-Eaton myasthenic syndrome (3.8%), sensory neuronopathy (1.9%), and limbic encephalitis (1.5%). Eighty-seven percent of all patients with PNDs had antibodies to SOX2 (62.5%), HuD (41.7%), or P/Q VGCC (50%), irrespective of their syndrome. Other neuronal antibodies were found at lower frequencies (GABAb receptor [12.5%] and N-type VGCC [20.8%]) or very rarely (GAD65, amphiphysin, Ri, CRMP5, Ma2, Yo, VGKC complex, CASPR2, LGI1, and NMDA receptor [all Conclusions: The spectrum of PNDs is broader and the frequency is higher than previously appreciated, and selected antibody tests (SOX2, HuD, VGCC) can help determine the presence of an SCLC.
- Published
- 2015
10. Neglected Parasitic Infections in the United States: Toxocariasis
- Author
-
Dana M, Woodhall, Mark L, Eberhard, and Monica E, Parise
- Subjects
Toxocariasis ,Articles ,United States ,Dogs ,Infectious Diseases ,Zoonoses ,Virology ,parasitic diseases ,Cats ,Animals ,Humans ,Larva Migrans ,Parasitology ,Toxocara - Abstract
Toxocariasis is a preventable parasitic disease that is caused by the dog and cat roundworms Toxocara cani and T. cati, respectively. Humans become infected when they accidently ingest infectious Toxocara eggs commonly found in contaminated soil; children are most often affected. Clinical manifestations of Toxocara infection in humans include ocular toxocariasis and visceral toxocariasis. Although infection with Toxocara can cause devastating disease, the burden of toxocariasis in the United States population remains unknown. In addition, risk factors for acquiring infection need to be better defined, and research needs to be conducted to better understand the pathophysiology and clinical course of toxocariasis. Development of diagnostic tests would enable clinicians to detect active infection, and determination of optimal drug regiments would ensure patients were appropriately treated. Addressing these public health gaps is necessary to understand and address the impact of toxocariasis in the United States.
- Published
- 2014
11. Toxocariasis: A Review for Pediatricians
- Author
-
Dana M. Woodhall and Anthony E. Fiore
- Subjects
Pediatrics ,medicine.medical_specialty ,Abdominal pain ,business.industry ,Mebendazole ,General Medicine ,Disease ,Ocular larva migrans ,medicine.disease ,Albendazole ,Surgery ,Deworming ,Infectious Diseases ,Parasitic disease ,Pediatrics, Perinatology and Child Health ,medicine ,Toxocariasis ,medicine.symptom ,business ,medicine.drug - Abstract
Toxocariasis is a parasitic disease caused by roundworms of cats and dogs. The disease is endemic throughout the United States and causes significant morbidity in children, including damage to the lungs, liver, or central nervous system, especially the eyes. Two well established clinical syndromes of disease include visceral and ocular toxocariasis. Symptoms of visceral toxocariasis include abdominal pain, cough, or wheezing. Vision loss or strabismus are common symptoms of ocular toxocariasis. Serologic testing for presence of Toxocara antibody is available, although a positive test result does not necessarily correlate with active clinical infection. Albendazole or mebendazole is the recommended treatment for visceral toxocariasis. Treatment options for ocular toxocariasis include corticosteroids or ophthalmic surgery; anthelminthic medications also may be used. Risk for toxocariasis can be reduced by handwashing after soil contact, routine pets deworming, discouraging geophagia, and appropriate disposal of pet feces.
- Published
- 2013
12. Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies
- Author
-
I Carrilho, Joana Damásio, Angela Vincent, M Woodhall, M A Santos, Maria Isabel Leite, Patrick Waters, and Ester Coutinho
- Subjects
Myoclonus ,Encephalomyelitis ,Immunoglobulins ,Neurological disorder ,Trismus ,Tachypnea ,Severity of Illness Index ,Receptors, Glycine ,medicine ,Humans ,Immunologic Factors ,Hyperekplexia ,business.industry ,Immunoglobulins, Intravenous ,Infant ,medicine.disease ,Muscle Rigidity ,Treatment Outcome ,Anesthesia ,Female ,Steroids ,Neurology (clinical) ,medicine.symptom ,business ,Stiff person syndrome ,Follow-Up Studies - Abstract
IMPORTANCE: Progressive encephalomyelitis with rigidity and myoclonus is characterized by rigidity, painful muscle spasms, hyperekplexia, and brainstem signs. Recently, glycine receptor alpha 1 antibodies have been described in adult patients with progressive encephalomyelitis with rigidity and myoclonus. We describe a pediatric case. OBSERVATIONS: A 14-month-old child developed startle-induced episodes of generalized rigidity and myoclonus, axial hyperextension, and trismus, without impairment of consciousness. Episodes occurred during wakefulness and sleep, lasted seconds, and were accompanied by moaning, tachypnea, and oxygen desaturation. Imaging, cerebrospinal fluid, endocrine, metabolic, and genetic screening findings were normal or negative. She was treated with intravenous steroids and immunoglobulins with resolution of symptoms, but she relapsed weeks later. At this time, episodes were more severe. Glycine receptor alpha 1 antibodies were found in serum (titer of 1:200, later 1:320) and cerebrospinal fluid (titer of 1:2). Treatment was restarted with intravenous steroids and immunoglobulins, with major improvement, and she began treatment with oral steroids. She had 4 milder relapses, with improvement after treatment adjustments. CONCLUSIONS AND RELEVANCE: To our knowledge, this is the first pediatric case of progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor alpha 1 antibodies, a potentially severe but treatable antibody-mediated neurological disorder.
- Published
- 2016
13. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
- Author
-
E Devenney, J Craig, Angela Vincent, M Woodhall, Maria Isabel Leite, J Kitley, Jacqueline Palace, and Patrick Waters
- Subjects
Adult ,Aquaporin 4 ,Male ,Neuromyelitis optica ,Adolescent ,biology ,business.industry ,Multiple sclerosis ,Neuromyelitis Optica ,Antibody titer ,medicine.disease ,Transverse myelitis ,Serology ,Myelin oligodendrocyte glycoprotein ,Immunology ,biology.protein ,Humans ,Medicine ,Female ,Myelin-Oligodendrocyte Glycoprotein ,Optic neuritis ,Neurology (clinical) ,Antibody ,business ,Autoantibodies - Abstract
Objectives: To report an association of myelin-oligodendrocyte glycoprotein (MOG) antibodies with aquaporin-4 (AQP4) antibody–seronegative neuromyelitis optica (NMO) and neuromyelitis optica spectrum disorder (NMOSD) in adults. Methods: We describe the clinical and serologic features of 4 adult patients with an NMO/NMOSD phenotype who had antibodies to MOG. Results: Twenty-seven adult AQP4-seronegative NMO/NMOSD patients were tested for MOG antibodies. Four patients (3 male, 1 female) with severe optic neuritis and/or longitudinally extensive transverse myelitis were positive. All 4 made good recoveries with steroids or plasma exchange. Two patients experienced recurrence of symptoms when corticosteroids were withdrawn quickly but none have experienced further relapses over a mean follow-up of 12 months, although 3 patients remain on treatment. Imaging abnormalities resolved fully following clinical recovery and MOG antibody titers fell in all 4 patients. MOG antibodies were not found in 44 AQP4 antibody–positive NMO/NMOSD patients, 75 adult patients with multiple sclerosis, or 47 healthy individuals. Conclusions: MOG antibody–associated NMO/NMOSD could account for some cases thought previously to be AQP4-seronegative NMO/NMOSD. Our 4 patients appear to have more favorable clinical outcomes than those with typical AQP4 antibody–mediated disease. However, further studies of NMO/NMOSD and other demyelinating conditions are required to help clarify the diagnostic and prognostic relevance of MOG antibodies.
- Published
- 2016
14. Ocular Toxocariasis: Epidemiologic, Anatomic, and Therapeutic Variations Based on a Survey of Ophthalmic Subspecialists
- Author
-
Dana M. Woodhall, Ramana S. Moorthy, Jeffrey L. Jones, Michelle C. Starr, Russell W. Read, Flora Lum, and Susan P. Montgomery
- Subjects
Adult ,Male ,Ocular toxocariasis ,Pediatrics ,medicine.medical_specialty ,Adolescent ,genetic structures ,Posterior pole ,Vision Disorders ,Diagnostic Techniques, Ophthalmological ,Subspecialty ,Young Adult ,Dogs ,Residence Characteristics ,Patient age ,medicine ,Animals ,Humans ,Eye Infections, Parasitic ,Practice Patterns, Physicians' ,Child ,Strabismus ,Societies, Medical ,Aged ,Toxocariasis ,business.industry ,Infant ,Toxocara canis ,Middle Aged ,medicine.disease ,United States ,eye diseases ,Surgery ,Ophthalmology ,Cross-Sectional Studies ,Child, Preschool ,Health Care Surveys ,Granuloma ,Cats ,Medicine ,Female ,Pediatric ophthalmology ,business ,Uveitis - Abstract
Purpose To assess the current burden of ocular toxocariasis (OT) and to gain knowledge regarding the diagnostic and treatment practices used in the ophthalmologic community in the United States. Design Web-based, cross-sectional survey. Participants Subspecialty ophthalmologists who are currently practicing in the United States. Methods An electronic survey was sent to 3020 ophthalmologic subspecialists belonging to the American Uveitis Society (AUS), the American Society of Retina Specialists (ASRS), or the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) to capture demographic, clinical, diagnostic, and treatment data on patients with OT seen in their practices between September 2009 and September 2010. Main Outcome Measures The demographic, epidemiologic, and clinical characteristics of each reported patient with OT. Results A total of 159 patients with OT were reported by 559 respondents (19%). The median patient age was 11.5 years (range, 1–66 years). Seventy-two patients (45%) with OT lived in the Southern region of the United States. Thirty-one (69%) of 45 patients with OT owned a dog or cat. Vision loss was reported in 46 (85%) of 54 patients with OT; 32 (71%) of 45 patients had permanent vision loss, 13 patients (29%) had temporary vision loss, and duration of vision loss was unreported for 1 patient. Of the 32 patients with OT with permanent vision loss, 30 (94%) had a subretinal granulomatous mass/scar, peripheral granuloma with traction bands, or posterior pole granuloma noted on ophthalmologic examination. Subretinal granulomatous mass/scar, vitritis, and scotoma were the most common ophthalmologic signs found on examination of patients with OT. Conclusions Ocular toxocariasis continues to occur in the United States, where it affects mainly children and causes permanent vision loss in many patients. Healthcare professionals should counsel patients and their family members about prevention strategies in an effort to decrease infection rates and morbidity due to Toxocara . Further improvement of diagnostic and treatment tools is needed to assist ophthalmologists in treating patients with OT. Financial Disclosure(s) The author(s) have no proprietary or commercial interest in any materials discussed in this article.
- Published
- 2012
15. IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG
- Author
-
Michelangelo Maestri, Saif Huda, Maria Isabel Leite, Anna De Rosa, Jeannine M. Heckmann, Leslie Jacobson, David Hilton-Jones, Patrick Waters, Angela Vincent, Angelina Maniaol, M Woodhall, Amelia Evoli, Judy Cossins, and Roberta Ricciardi
- Subjects
0301 basic medicine ,Neurology ,Neurology (clinical) ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Acetylcholine receptor ,Cell specific ,biology ,business.industry ,Pathogenicity ,medicine.disease ,Clinical disease ,Primary and secondary antibodies ,In vitro ,Myasthenia gravis ,Settore MED/26 - NEUROLOGIA ,030104 developmental biology ,Immunology ,biology.protein ,Antibody ,business ,030217 neurology & neurosurgery - Abstract
Objective:To increase the detection of MuSK-Abs using a CBA and test their pathogenicity.Methods:Sera from 69 MuSK-RIA–positive patients with myasthenia gravis (MG) (Definite MuSK-MG), 169 patients negative for MuSK-RIA and AChR-RIA (seronegative MG, SNMG), 35 healthy individuals (healthy controls, HCs), and 16 NMDA receptor-Ab–positive (NMDAR-Ab) disease controls were tested for binding to MuSK on a CBA using different secondary antibodies.Results:Initially, in addition to 18% of SNMG sera, 11% of HC and 19% of NMDAR-Ab sera showed positive binding to MuSK-transfected cells; this low specificity was due to anti-IgG(H+L) detection of IgM bound nonspecifically to MuSK. Using an IgG Fc gamma-specific secondary antibody, MuSK-Abs were detected by CBA in 68/69 (99%) of Definite MuSK-MG, 0/35 HCs, 0/16 NMDAR-Ab, and 14/169 (8%) of SNMG sera, providing increased sensitivity with high specificity. The RIA-negative, CBA-positive MuSK-IgG sera, but not IgM-MuSK–binding sera, reduced agrin-induced AChR clustering in C2C12 myotubes, qualitatively similar to RIA-positive MuSK-Abs.Conclusions:An IgG-specific MuSK-CBA can reliably detect IgG MuSK-Abs and increase sensitivity. In the MuSK-CBA, IgG specificity is essential. The positive sera demonstrated pathogenic potential in the in vitro AChR-clustering assay, although less effective than Definite MuSK-MG sera, and the patients had less severe clinical disease. Use of IgG-specific secondary antibodies may improve the results of other antibody tests.Classification of evidence:This study provides Class III evidence that an IgG-specific MuSK-CBA identifies patients with MG.
- Published
- 2017
16. Inhibition of the tyrosine phosphatase Shp2 alleviates the pathogeniceff ects of MuSK antibodies in vitro
- Author
-
Rosa Ricciardi, Michelangelo Maestri, Saif Huda, A. De Rosa, M Woodhall, David Beeson, Michelangelo Cao, Judy Cossins, and A Vincent
- Subjects
0301 basic medicine ,biology ,Chemistry ,In vitro ,03 medical and health sciences ,030104 developmental biology ,Neurology ,Biochemistry ,TYROSINE PHOSPHATASE SHP2 ,Pediatrics, Perinatology and Child Health ,biology.protein ,Neurology (clinical) ,Antibody ,Genetics (clinical) - Published
- 2017
17. Prevalence of Strongyloides stercoralis antibodies among a rural Appalachian population--Kentucky, 2013
- Author
-
Stephanie M. Davis, Dana M. Woodhall, Elizabeth B. Gray, Sukwan Handali, Amanda L. Beaudoin, Rebekah E. Marshall, Elizabeth S. Russell, Cheryl D. Davis, and Isabel McAuliffe
- Subjects
Adult ,Male ,Rural Population ,Veterinary medicine ,Adolescent ,Population ,Antibodies, Helminth ,Kentucky ,Strongyloides stercoralis ,Young Adult ,Strongyloides infection ,Virology ,Prevalence ,Medicine ,Animals ,Humans ,Positive test ,education ,Child ,Aged ,education.field_of_study ,biology ,Transmission (medicine) ,business.industry ,Articles ,Middle Aged ,biology.organism_classification ,Infectious Diseases ,Cross-Sectional Studies ,Child, Preschool ,Strongyloides ,biology.protein ,Strongyloidiasis ,Parasitology ,Female ,Antibody ,business ,Demography - Abstract
We investigated whether Strongyloides infection remains endemic in rural Kentucky's Appalachian regions; 7 of 378 (1.9%) participants tested positive for Strongyloides antibodies. We identified no statistically significant association between a positive test and travel to a known endemic country (P = 0.58), indicating that transmission in rural Kentucky might be ongoing.
- Published
- 2014
18. Exploring innovative ways to conduct coverage surveys for neglected tropical diseases in Malawi, Mali, and Uganda
- Author
-
Jennifer B. Harris, Els Mathieu, M. Dembele, Square Mkwanda, Christine Dubray, Caitlin M. Worrell, Naomi A. Drexler, Harriet Lwanga, and Dana M. Woodhall
- Subjects
Adult ,Male ,Malawi ,Resource (biology) ,Adolescent ,Veterinary (miscellaneous) ,Survey result ,Mali ,Survey methodology ,Young Adult ,Parasitic Diseases ,Humans ,Uganda ,Mass drug administration ,Socioeconomics ,Child ,Aged ,Estimation ,Aged, 80 and over ,Tropical Climate ,Antiparasitic Agents ,business.industry ,Data Collection ,Environmental resource management ,Infant ,Neglected Diseases ,Middle Aged ,Drug Utilization ,Infectious Diseases ,Geography ,Insect Science ,Child, Preschool ,Neglected tropical diseases ,Parasitology ,Female ,Religious leader ,business - Abstract
Currently, a 30-cluster survey to monitor drug coverage after mass drug administration for neglected tropical diseases is the most common methodology used by control programs. We investigated alternative survey methodologies that could potentially provide an estimation of drug coverage. Three alternative survey methods (market, village chief, and religious leader) were conducted and compared to the 30-cluster method in Malawi, Mali, and Uganda. In Malawi, drug coverage for the 30-cluster, market, village chief, and religious leader methods were 66.8% (95% CI 60.3–73.4), 74.3%, 76.3%, and 77.8%, respectively. In Mali, results for round 1 were 62.6% (95% CI 54.4–70.7), 56.1%, 74.8%, and 83.2%, and 57.2% (95% CI 49.0–65.4), 54.5%, 72.2%, and 73.3%, respectively, for round 2. Uganda survey results were 65.7% (59.4–72.0), 43.7%, 67.2%, and 77.6% respectively. Further research is needed to test different coverage survey methodologies to determine which survey methods are the most scientifically rigorous and resource efficient.
- Published
- 2013
19. List of Contributors
- Author
-
Jose M Acuin, Rodney D Adam, Tsiri Agbenyega, AM Shamsir Ahmed, Tahmeed Ahmed, S Asad Ali, Gregory M Anstead, George E Armah, Stephen J Aston, Ronald C Ballard, Elizabeth D Barnett, Imelda Bates, Charles W Beadling, Nicholas J Beeching, Michael L Bennish, Caryn Bern, Frank J Bia, Brian H Bird, Allyson K Bloom, Gerard Bodeker, Robert W Bradsher, Nynke van den Broek, Simon Brooker, John T Brooks, W Abdullah Brooks, Philippe Brouqui, Michael Brown, Fabrizio Bruschi, Donald AP Bundy, Danai Bunnag, Benjamin Caballero, Michael V Callahan, Aulasa J Camerlin, Grant L Campbell, Jonathan R Carapetis, Enitan D Carrol, Eric Caumes, Remi N Charrel, Anna M Checkley, Mala Chhabra, Tepirou Chher, Charlotte M Chiong, M Jobayer Chisti, David C Christiani, Bradley A Connor, Edward S Cooper, Philip J Cooper, R Richard Coughlin, John H Cross, Nigel N Cunliffe, Mark Danta, Nicholas PJ Day, Paron Dekumyoy, Nilanthi deSilva, Gregory Deye, Rebecca Dillingham, H Rogier van Doorn, Barbara Doudier, Michel Drancourt, Françoise Dromer, Michael Eddleston, Samer S El-Kamary, Jeremy Farrar, Wafaie Fawzi, Nicholas A Feasey, Vanessa Field, Marc Fischer, Susan Fisher-Hoch, Kevin Forsyth, LeAnne M Fox, Arthur M Friedlander, Gerson Galdos-Cardenas, Hector H Garcia, Lynne S Garcia, Anna-Maria Geretti, Achilleas Gikas, Robert H Gilman, Victor Javier Sanchez Gonzalez, Melita A Gordon, Richard A Gosselin, Stephen M Graham, Alison D Grant, James J Gray, John R Graybill, Bertrand Graz, Stephen Green, Jeffrey K Griffiths, Bruno Gryseels, Duane J Gubler, Rathi Guhadasan, Aron J Hall, Davidson Hamer, David Harley, Jason B Harris, Amy L Hartman, Oliver Hassall, Roderick J Hay, Chris F Heyns, David R Hill, Martin H Hobdell, Caroline M den Hoed, Meredith L Holtz, M Iqbal Hossain, Peter J Hotez, Eric R Houpt, Cynthia R Howard, Chien-Ching Hung, Munirul Islam, Elizabeth Joekes, Victoria Johnston, Sam Kampondeni, Gagandeep Kang, Powel Kazanjian, Jay S Keystone, Wasif Ali Khan, Arthur Y Kim, Christopher L King, Amy D Klion, Richard Knight, Peter James Krause, Sanjeev Krishna, Ernst J Kuipers, Angelle D LaBeaud, David G Lalloo, Xavier De Lamballerie, Saba Lambert, Regina C LaRocque, John Lawrenson, Myron M Levine, Daniel H Libraty, Diana NJ Lockwood, Kinke M Lommerse, Olivier Lortholary, Rogelio López-Vélez, Benjamin A Lopman, David Mabey, Alan J. Magill, Ciro Maguiña, Syed Faisal Mahmood, Kathryn Maitland, Hadi Manji, Barbara J Marston, Anu Mathew, Christine E Mathews, Max Maurin, Paola J Maurtua-Neumann, Philippe Mayaud, Bongani M Mayosi, Joseph B McCormick, Stephen McKew, Susan LF McLellan, Peter C McMinn, Joseph D Mega, Donald E Meier, Matthieu Million, Veena Mittal, Elizabeth M Molyneux, Susan P Montgomery, Pedro Morera, Pedro L Moro, William J Moss, K Darwin Murrell, Osamu Nakagomi, Toyoko Nakagomi, Neha Nanda, James P Nataro, Eileen E Navaro, Ronald C Neafie, Ricardo Negroni, Ann M Nelson, Paul N Newton, Robert Newton, Stuart T Nichol, Francesca F Norman, Marcio RT Nunes, Thomas B Nutman, Richard A Oberhelman, Edward C Oldfield, Eloy E Ordaya, Christopher D Paddock, Slobodan Paessler, Ilias C Papanikolaou, Georgios Pappas, Luc Paris, Philippe Parola, Christopher M Parry, Manish M Patel, Sharon J Peacock, Rosanna Peeling, Hans Persson, Philip J Peters, Jonathan J Phillips, Richard O Phillips, Farah Naz Qamar, Atif Rahman, Jamilla Rajab, Didier Raoult, Michael F Rein, Aurélié Renvoisé, Jean-Marc Reynes, Frank O Richards, John Richens, Anne W Rimoin, Robert Riviello, Ema G Rodrigues, Allan R Ronald, Benjamin M Rosenthal, David Rosmarin, Ernesto Ruiz-Tiben, Edward T Ryan, Debasish Saha, Arturo Saavedra, Peter M Schantz, Tony Schountz, Sandra K Schumacher, James J Sejvar, Aisha Sethi, Kwonjune J Seung, Om Prakash Sharma, Trueman W Sharp, Anuraj H Shankar, Sonya S Shin, David R Shlim, Nicholas J van Sickels, Freddy Sitas, Thomas L Snelling, Cristina Socolovschi, Tom Solomon, J Erin Staples, Robert C Stewart, August Stich, G Thomas Strickland, Kathryn N Suh, Andreas Suhrbier, Khuanchai Supparatpinyo, Catherine G Sutcliffe, Brett E Swierczewski, John L Tarpley, Hugh R Taylor, Terrie Taylor, Harry J Thomas, C Louise Thwaites, Guy E Thwaites, Tejpratap SP Tiwari, Phan Van Tu, Angus W Turner, Edouard Vannier, Pedro FC Vasconcelos, Fransisco Vega-López, Jorge J Velarde, Nicholas J Vietri, Govinda S Visvesvara, Keyur S Vyas, Katie Wakeham, Thomas J Walsh, Mark H Wansbrough-Jones, David A Warrell, Mary J Warrell, Haider J Warraich, George Watt, Yupaporn Wattanagoon, Dorn Watthanakulpanich, Scott C Weaver, Rachel B Webman, Paul J Weidle, Louis M Weiss, Nicholas J White, Christopher JM Whitty, Dana M Woodhall, Stephen G Wright, Ramnik J Xavier, Lihua Xiao, Hongjie Yu, and Anita KM Zaidi
- Published
- 2013
20. Toxocariasis
- Author
-
Dana M Woodhall
- Published
- 2013
21. Bupropion-induced stuttering treated with haloperidol
- Author
-
Dana M. Woodhall and Matthew W. McAllister
- Subjects
Bupropion ,medicine.medical_specialty ,Stuttering ,business.industry ,Acquired stuttering ,General Medicine ,Audiology ,Toxicology ,030227 psychiatry ,03 medical and health sciences ,0302 clinical medicine ,Haloperidol ,medicine ,030212 general & internal medicine ,medicine.symptom ,business ,medicine.drug - Abstract
Sir,Acquired stuttering in previously fluent individuals may be neurogenic and is less common than developmental stuttering.[1] There have been a variety of psychotropic substances that have been a...
- Published
- 2016
22. PP08.9 – 2594: Glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus (PERM) presenting as an abnormal startle response in an adolescent girl
- Author
-
A. Vincent, B. Amin, P. Munot, R. Robinson, S. Boyd, C. Hemingway, A. Patel, and M. Woodhall
- Subjects
Startle response ,medicine.diagnostic_test ,Encephalomyelitis ,Myoclonic Jerk ,General Medicine ,medicine.disease ,Anesthesia ,Pediatrics, Perinatology and Child Health ,medicine ,Neurology (clinical) ,Levetiracetam ,Headaches ,medicine.symptom ,Psychology ,Glycine receptor ,Myoclonus ,muscle spasm ,medicine.drug - Abstract
Objective To describe a young girl in whom stimulus sensitive spasms were a diagnostic clue to the underlying glycine receptor antibody mediated progressive encephalomyelitis with rigidity and myoclonus (PERM) which has been described mainly in adults. Methods We illustrate the clinical data from the case-notes with a video recording of stimulus-sensitive spasms. Results A previously well 15-year-old girl presented with a traumatic head injury after falling down the stairs. The noise from a doorbell had triggered a severe muscle spasm causing the fall. She sustained a complex skull fracture with coup-contrecoup brain injury. She had previously been evaluated over five months for stimulus-sensitive whole body spasms with axial hyperextension without impairment of consciousness. She also had daily stimulus-sensitive myoclonic jerks, headaches and subtle cognitive impairment over the preceding year. Whilst on the paediatric intensive care unit, she was noted to have spontaneous and stimulus-sensitive muscle spasms (EMG duration 360–680 ms with no EEG correlate). She also developed generalised tonic clonic seizures, which were treated with Levetiracetam. A diagnosis of PERM was considered and glycine receptor antibodies were found to be strongly positive in serum and CSF. VGKC-complex antibodies were also weakly positive but GAD and NMDAR antibodies were negative. Oligoclonal bands were positive in CSF but negative in serum. Paraneoplastic antibodies were negative. Brain MRI showed contusions in the right hemisphere. Body imaging did not identify any tumours. Glycine receptor gene analysis is awaited. Her spasms have improved with a residual mild startle response to touch or loud auditory stimuli. She has a residual left hemiparesis. She was not treated with immunomodulation but will be followed up, and immunotherapy considered if she does not continue to improve and antibodies persist. Conclusion Glycine receptor antibody-mediated progressive encephalomyelitis with rigidity and myoclonus can present in children as stimulus-sensitive muscle spasms.
- Published
- 2015
23. OP87 – 3001: Paediatric neurological syndromes associated with glycine receptor antibodies
- Author
-
F. Brilot, Karine Lascelles, P. Munot, Yael Hacohen, S. Kariyawasam, M. Pike, Russell C. Dale, A. Vincent, J. Suleiman, J. Gadian, S. Pillai, Ming K. Lim, and M. Woodhall
- Subjects
Pathology ,medicine.medical_specialty ,Pediatrics ,medicine.diagnostic_test ,business.industry ,Encephalopathy ,General Medicine ,Electroencephalography ,medicine.disease ,Atrophy ,Pediatrics, Perinatology and Child Health ,Cohort ,medicine ,Clinical significance ,Neurology (clinical) ,medicine.symptom ,business ,Myoclonus ,Stiff person syndrome ,Encephalitis - Abstract
Background In patients with glycine receptor antibodies (GlyRAb), a range of neurological syndromes that includes Stiff Person Syndrome (SPS) and its more severe variant Progressive Encephalitis with Rigidity and Myoclonus (PERM) have recently been reported in a predominantly adult cohort (Carvajal-Gonzalez et al., Brain 2014;137(Pt 8):2178–92). Objectives To report the clinical features and outcome of children with GlyR-Ab. Methods Cases were identified from samples sent to the Nuffield Department of Clinical Neurology, Oxford for a range of neuronal surface antibody testing. Results Six girls with a mean age of 8 years (median 7.5; range 1–15) were identified (2 London, 1 Oxford, and 3 Australia). The children presented with refractory focal seizures (n=2), or cognitive/behavioural changes (n=4) of whom two had tremor and gait abnormalities and one features of PERM. During the course of the illness, seizures featured in 5 patients and cognitive/behavioural changes in all. Electroencephalogram (EEG) during the illness revealed features of encephalopathy (n=3) and focal/multifocal epileptiform discharges (n=2). Two children had early imaging features of brain inflammation, and in another 2, global atrophy were identified on serial imaging despite normal acute scans. GlyR-Abs were detected in the serum (n=6) and/or CSF (n=2). Co-occurrence of low levels ( Conclusions The paediatric phenotype is predominated by female sex, seizures, and, where PERM occurs, it is associated with additional features. The clinical relevance of GlyR antibodies needs to be determined, to help guide therapies.
- Published
- 2015
24. Human Capital: Educational Aspects
- Author
-
M. Woodhall
- Subjects
Physical capital ,Financial capital ,Public economics ,Individual capital ,Economic capital ,Capital (economics) ,Economics ,Human capital ,Capital formation ,Education economics - Abstract
The economic concept ‘human capital’ refers to the fact that education and training can be regarded as a form of investment that will increase future levels of income for both individuals and society, by making people more productive, in the same way as buildings or machinery represent investment in physical capital. Economists traditionally measure the relationship between costs and benefits of investment by estimating ‘rates of return.’ This article examines the applicability of the economic concept of human capital to education, summarizes research and literature on educational aspects of human capital, discusses ways in which estimates of rates of return to education and the links between education, employment and economic growth have influenced education policy, particularly on financing of education, and examines criticisms of human capital theories, including the idea that education may represent a ‘screening device,’ rather than a genuinely productive form of investment. The article ends with a discussion of the more recently developed concept of ‘social capital,’ which challenges narrow definitions of human capital.
- Published
- 2001
25. The Causes of Graduate Unemployment in India (1969)
- Author
-
M. Woodhall and M. Blaug
- Subjects
media_common.quotation_subject ,Unemployment ,Development economics ,Graduate unemployment ,Economics ,Demographic economics ,High incidence ,Investment (macroeconomics) ,health care economics and organizations ,media_common - Abstract
The figures in Table 11.1 show that all levels of education in India are profitable investments for private individuals at 8 per cent; indeed, they remain profitable even at cut-off rates as high as 10 per cent; at higher rates, a first degree at least ceases to be obviously profitable. Apart from the first general degree, however, the results are insensitive to alternative rates as high as 12 per cent. Thus, despite the fact that educated unemployment has eroded some of the financial returns of additional education, and despite the fact that there is a relatively high incidence of unemployment even for the better educated, additional education right up to the degree level still remains a profitable investment for the average Indian parent.
- Published
- 1999
26. Use of Geospatial Modeling to Predict Schistosoma mansoni Prevalence in Nyanza Province, Kenya
- Author
-
Bernard Abudho, Elizabeth Matey, Dana M. Woodhall, W. Evan Secor, Susan P. Montgomery, Ryan E. Wiegand, Michael Wellman, Pauline M. N. Mwinzi, and Diana M. S. Karanja
- Subjects
Spatial Epidemiology ,Epidemiology ,Prevalence ,lcsh:Medicine ,Population Modeling ,Disease Mapping ,Schistosomiasis ,lcsh:Science ,Child ,education.field_of_study ,Multidisciplinary ,Geography ,biology ,Ecology ,Schistosoma mansoni ,Infectious Diseases ,Regression Analysis ,Medicine ,Research Article ,Neglected Tropical Diseases ,Clinical Research Design ,Population ,Infectious Disease Epidemiology ,Normalized Difference Vegetation Index ,Geospatial predictive modeling ,Environmental health ,parasitic diseases ,Parasitic Diseases ,medicine ,Animals ,Humans ,education ,Biology ,Disease burden ,Spatial Analysis ,Population Biology ,Land use ,lcsh:R ,Computational Biology ,Models, Theoretical ,biology.organism_classification ,medicine.disease ,Kenya ,Multivariate Analysis ,lcsh:Q ,Infectious Disease Modeling - Abstract
Background Schistosomiasis, a parasitic disease that affects over 200 million people, can lead to significant morbidity and mortality; distribution of single dose preventative chemotherapy significantly reduces disease burden. Implementation of control programs is dictated by disease prevalence rates, which are determined by costly and labor intensive screening of stool samples. Because ecological and human factors are known to contribute to the focal distribution of schistosomiasis, we sought to determine if specific environmental and geographic factors could be used to accurately predict Schistosoma mansoni prevalence in Nyanza Province, Kenya. Methodology/Principal Findings A spatial mixed model was fit to assess associations with S. mansoni prevalence in schools. Data on S. mansoni prevalence and GPS location of the school were obtained from 457 primary schools. Environmental and geographic data layers were obtained from publicly available sources. Spatial models were constructed using ArcGIS 10 and R 2.13.0. Lower S.mansoni prevalence was associated with further distance (km) to Lake Victoria, higher day land surface temperature (LST), and higher monthly rainfall totals. Altitude, night LST, human influence index, normalized difference vegetation index, soil pH, soil texture, soil bulk density, soil water capacity, population, and land use variables were not significantly associated with S. mansoni prevalence. Conclusions Our model suggests that there are specific environmental and geographic factors that influence S. mansoni prevalence rates in Nyanza Province, Kenya. Validation and use of schistosomiasis prevalence maps will allow control programs to plan and prioritize efficient control campaigns to decrease schistosomiasis burden.
- Published
- 2013
27. Earnings and Education
- Author
-
M. Woodhall
- Subjects
Labour economics ,Earnings ,business.industry ,media_common.quotation_subject ,Distribution (economics) ,Investment (macroeconomics) ,Human capital ,Economics ,Redistribution of income and wealth ,business ,Productivity ,Sophistication ,media_common ,Education economics - Abstract
Publisher Summary This chapter discusses the earnings and education. It is a well-established fact that educated workers earn higher wages or salaries than those who are illiterate or those who have completed less education, or have lower educational qualifications. The relationship between education and earnings is important on distributional grounds because the distribution of educational opportunities will have an impact on the future distribution of income, so that governments committed to long-term redistribution of income must consider the role of education. The links between education and earnings are also of crucial importance in decisions about the efficient allocation of resources. In the contribution of education to earnings, there has been a considerable improvement in the sophistication of techniques of analysis, and in the availability of data. The basic assumption of the notion that education is a form of investment in human capital is that education raises the productivity of workers and that the higher earnings of the educated reflect the value of their product.
- Published
- 1987
28. Student Loans
- Author
-
M. Woodhall
- Published
- 1987
29. Financing Vocational and Industrial Education
- Author
-
M. Woodhall
- Subjects
Finance ,Higher education ,business.industry ,Total cost ,Vocational education ,Medicine ,General education ,Industrial education ,business ,Training (civil) - Abstract
Publisher Summary This chapter discusses the financing vocational and industrial education. Vocational and industrial education and training takes many forms. In the past, the bulk of all vocational and industrial education was provided on the job by employers for their own workers. The costs of this education and training were shared between the employers, who provided personnel, equipment, and other facilities, and the trainees, who accepted low wages during the period of training. However, as the skill requirements of the jobs became more complex, the need for more formal types of vocational education and training was widely accepted. Economists have also been much concerned with the question of whether the distinction between general and vocational education is valid. It is difficult to estimate the total costs of vocational education and industrial training, as employers do not necessarily keep accurate records of the time or expenditure devoted to on-the-job training, and it is difficult to estimate the contribution of individual trainees. Another recent development that has changed the pattern of financing vocational and industrial education in some countries is the provision of paid educational leave for employees, which means that employers continue to pay wages to employees while they receive part-time or full-time vocational or general education. In other words, paid educational leave is simply one way of distributing the costs of vocational education and training between employers, workers, and taxpayers.
- Published
- 1987
30. Financing Adult Education
- Author
-
M. Woodhall
- Subjects
Finance ,Economic growth ,Adult education ,Public economics ,business.industry ,Political science ,Vocational education ,Qualitative evidence ,Education policy ,Comparative education ,business ,Variety (cybernetics) ,Education economics - Abstract
Publisher Summary This chapter explains various financing methods for adult education. The term “adult education” refers to a wide range of educational activities in which adults take part and includes vocational education and training, nonvocational courses, correspondence education, and full-time and part-time courses. Because of the very wide range of educational activities included in the term “adult education” there is a wide variety of financing methods and mechanisms adopted in different countries. The Organization for Economic Co-operation and Development (OECD) carried out a series of studies on adult education that was published in 1977 and attempted to collect statistics and quantitative evidence about the magnitude and characteristics of adult education in a number of OECD member countries. In most countries finance for adult education is provided from both public and private sources. Central and local governments frequently provide funds either out of general taxation or, in a few cases, out of specific, earmarked taxes.
- Published
- 1989
31. Economics of Education: A Review
- Author
-
M. Woodhall
- Subjects
Labour economics ,Goods and services ,Physical capital ,business.industry ,Capital (economics) ,Economics education ,Economics ,Distribution (economics) ,Education policy ,business ,Investment (macroeconomics) ,Education economics - Abstract
Publisher Summary This chapter discusses the economics of education. Contribution of education to economic growth, the profitability of investment in education, the role of educated manpower in economic development , the costs of education, the finance of education, and more recently studies of the effects of education on the distribution of income and wealth are the factors considered when economics of education is done. Economic theories of capital and investment tend to concentrate on investment in physical capital, such as buildings, factories, and machines that generate income in the form of production of goods and services. The costs of education are measured in terms of the total resources devoted to education, which economists call the opportunity cost. Cost-effectiveness analysis is used to compare the efficiency of alternative ways of achieving the same objective. Educated manpower is one of the most crucial inputs in the economy of any country. Students receive financial aid in the form of scholarships, bursaries, grants, or subsidized loans, which help to reduce the financial burden of fees or of the students' living expenses. There is a fixed and stable relationship between the level of educational qualifications of workers and the level of output of an industry or sector of the economy.
- Published
- 1987
32. Financing Adult Education for Employment
- Author
-
M. Woodhall
- Subjects
Finance ,Value (ethics) ,ComputingMilieux_THECOMPUTINGPROFESSION ,business.industry ,Total cost ,Distribution (economics) ,Industrial education ,Training (civil) ,Adult education ,Work (electrical) ,Vocational education ,ComputingMilieux_COMPUTERSANDEDUCATION ,Medicine ,business - Abstract
Publisher Summary This chapter highlights financing adult education for employment. Vocational and industrial education and training takes many forms. In the past, the bulk of all vocational and industrial education was provided on the job by employers for their own workers. The costs of this education and training were shared between the employers, who provided personnel, equipment, and other facilities, and the trainees, who accepted low wages during the period of training. Vocational schools were established, and new types of combined on-the-job and off-the-job training were created. It is difficult to estimate the total costs of vocational education and industrial training, because employers do not necessarily keep accurate records of the time or expenditure devoted to on-the-job training, and it is difficult to estimate the contribution of individual trainees, because this would require estimates of the value of their productive work and the distribution of their time between learning and producing. However, there are many practical and conceptual difficulties involved in estimating the total costs of vocational education and industrial training.
- Published
- 1989
33. Cost–Effectiveness Analysis in Education
- Author
-
M. Woodhall
- Subjects
Alternative methods ,Measure (data warehouse) ,Risk analysis (engineering) ,Management science ,Educational resources ,Economics ,Cost-effectiveness analysis - Abstract
Publisher Summary This chapter discusses the cost effectiveness analysis in education. It is a technique for measuring the relationship between the total inputs, or costs, of a project or activity, and its outputs or objectives. Both costs and effectiveness must be quantified, but it is not necessary to measure them in monetary terms. Cost-effectiveness analysis can take two different forms. In the first case, a comparison is made between the alternative ways of achieving the same objective, to identify that with the lowest cost. The other method of using cost-effectiveness analysis is to compare two or more schools or other institutions with similar levels of cost to discover which achieves the highest level of output or results. Nevertheless, despite the difficulty of defining and measuring the output of education, it is necessary to find some way of comparing the efficiency of different institutions, of choosing between alternative methods of achieving the same or similar objectives, and of identifying the most effective ways of using educational resources.
- Published
- 1987
34. Cost Analysis in Education
- Author
-
M. Woodhall
- Subjects
Marginal cost ,Actuarial science ,Cost estimate ,Total cost ,Total absorption costing ,Carrying cost ,ComputingMilieux_COMPUTERSANDEDUCATION ,Relevant cost ,Economics ,Variable cost ,Implicit cost - Abstract
Publisher Summary This chapter discusses cost analysis in education. The cost of education is of crucial importance to educational planners and policy makers, but there are a number of different ways of defining and measuring cost, so that it is important to distinguish between different concepts of cost before attempting to analyze the costs of education. The inputs of education can be measured in terms of money or of the real resources that are used in the educational process, namely, the time of teachers, students, and other staff and books, materials, equipment, and buildings. All these resources have alternative uses. The opportunity cost of education can be measured in terms of the cost to the individual or to society as a whole. The cost of education to individual students or their families includes expenditure on fees, books, and equipment, and also earnings forgone. Cost analysis may be concerned with the total costs of education or with unit costs, which measure the costs of educating one pupil or student. For some purposes, however, it is necessary to measure the additional costs incurred when one additional student is enrolled. The additional cost attributable to one extra student is called the marginal cost, or sometimes the incremental cost. It is measured by the increase in total costs which occurs as a result of increasing enrolment by one unit.
- Published
- 1987
35. Human Capital Concepts
- Author
-
M. Woodhall
- Subjects
Labour economics ,Physical capital ,Individual capital ,Return on investment ,Capital (economics) ,Fixed investment ,Capital employed ,Economics ,Return of capital ,Investment (macroeconomics) - Abstract
Publisher Summary The concept of human capital refers to the fact that human beings invest in themselves, by the means of education, training, or other activities, which raises their future income by increasing their lifetime earnings. The term investment refers to expenditure on assets that will produce income in the future and contrast investment expenditure with consumption, which produces immediate satisfaction or benefits but does not create future income. It is possible to measure the profitability of investment in human capital using the same techniques of cost benefit analysis and investment appraisal that have been traditionally applied to physical capital. The profitability, or rate of return on investment, is a measure of the expected yield of the investment, in terms of the future benefits or income stream generated by the capital compared with the cost of acquiring the capital asset. Explanations of the concept of human capital suggest that education or training raised the productivity of workers. Migration, as well as health care, can all increase earning capacity, and can therefore be regarded as investment in human capital.
- Published
- 1987
36. Student Fees
- Author
-
M. Woodhall
- Published
- 1987
37. The Causes of Graduate Unemployment in India
- Author
-
E. G. West, M. Blaug, P. R. G. Layard, and M. Woodhall
- Subjects
Economics and Econometrics - Published
- 1971
38. Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
- Author
-
Chen B, Gomez-Figueroa E, Redenbaugh V, Francis A, Satukijchai C, Wu Y, Messina S, Sa M, Woodhall M, Paul F, Robertson NP, Lim M, Wassmer E, Kneen R, Huda S, Blain C, Halfpenny C, Hemingway C, O'Sullivan E, Hobart J, Fisniku LK, Martin RJ, Dobson R, Cooper SA, Williams V, Waters P, Chen JJ, Pittock SJ, Ramdas S, Leite MI, Flanagan EP, Geraldes R, and Palace J
- Subjects
- Humans, Retrospective Studies, Chronic Disease, Recurrence, Myelin-Oligodendrocyte Glycoprotein, Autoantibodies
- Abstract
Objective: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) can be monophasic or relapsing, with early relapse being a feature. However, the relevance of early relapse on longer-term relapse risk is unknown. Here, we investigate whether early relapses increase longer-term relapse risk in patients with MOGAD., Methods: A retrospective analysis of 289 adult- and pediatric-onset patients with MOGAD followed for at least 2 years in 6 specialized referral centers. "Early relapses" were defined as attacks within the first 12 months from onset, with "very early relapses" defined within 30 to 90 days from onset and "delayed early relapses" defined within 90 to 365 days. "Long-term relapses" were defined as relapses beyond 12 months. Cox regression modeling and Kaplan-Meier survival analysis were used to estimate the long-term relapse risk and rate., Results: Sixty-seven patients (23.2%) had early relapses with a median number of 1 event. Univariate analysis revealed an elevated risk for long-term relapses if any "early relapses" were present (hazard ratio [HR] = 2.11, p < 0.001), whether occurring during the first 3 months (HR = 2.70, p < 0.001) or the remaining 9 months (HR = 1.88, p = 0.001), with similar results yielded in the multivariate analysis. In children with onset below aged 12 years, only delayed early relapses were associated with an increased risk of long-term relapses (HR = 2.64, p = 0.026)., Interpretation: The presence of very early relapses and delayed early relapses within 12 months of onset in patients with MOGAD increases the risk of long-term relapsing disease, whereas a relapse within 90 days appears not to indicate a chronic inflammatory process in young pediatric-onset disease. ANN NEUROL 2023;94:508-517., (© 2023 American Neurological Association.)
- Published
- 2023
- Full Text
- View/download PDF
39. Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis.
- Author
-
Kwon YN, Woodhall M, Sung JJ, Kim KK, Lim YM, Kim H, Kim JE, Baek SH, Kim BJ, Park JS, Seok HY, Kim DS, Kwon O, Park KH, Sohn E, Bae JS, Yoon BN, Kim NH, Ahn SW, Choi K, Oh J, Park HJ, Shin KJ, Lee S, Park J, Kim SH, Seok JI, Bae DW, An JY, Joo IS, Choi SJ, Nam TS, Kim S, Park KJ, Kwon KH, Waters P, and Hong YH
- Subjects
- Humans, Retrospective Studies, Receptors, Cholinergic, Autoantibodies, Enzyme-Linked Immunosorbent Assay, Receptor Protein-Tyrosine Kinases, Myasthenia Gravis
- Abstract
Background: We aimed to evaluate the diagnostic accuracy of enzyme-linked immunosorbent assay (ELISA) for anti-muscle specific tyrosine kinase (MuSK) antibody (Ab) in a large cohort of anti-acetylcholine receptor (AChR) Ab-negative generalized myasthenia gravis (MG), and also to investigate clinical contexts for the diagnosis of MuSK MG., Methods: A retrospective study of 160 patients with a clinical suspicion of AChR Ab-negative generalized MG was performed. The serum samples were tested for anti-clustered AChR Ab by cell-based assay (CBA), anti-MuSK Ab by ELISA, CBA and/or radioimmunoprecipitation assay (RIPA). Clinical data were compared between anti-MuSK Ab-positive MG and double seronegative (AChR and MuSK) MG groups., Results: After excluding non-MG and clustered AChR Ab-positive patients, we identified 89 patients as a cohort of AChR Ab-negative generalized MG. Anti-MuSK Ab was positive by ELISA in 22 (24.7%) patients. While CBA identified five additional anti-MuSK Ab-positive patients, the results of ELISA were mostly consistent with CBA and RIPA with Cohen's kappa of 0.80 and 0.90, respectively (p < 0.001). The most frequent differential diagnosis was motor neuron disease particularly of bulbar onset which showed remarkably overlapping clinical and electrophysiological features with MuSK MG at presentation., Conclusion: While confirming the highest sensitivity of CBA for detecting anti-MuSK Ab, our results highlight the clinical pitfalls in making a diagnosis of MuSK MG and may support a diagnostic utility of MuSK-ELISA in clinical practice., (© 2022. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
40. Antibodies Produced by CLL Phenotype B Cells in Patients With Myasthenia Gravis Are Not Directed Against Neuromuscular Endplates.
- Author
-
Ingelfinger F, Kramer M, Lutz M, Widmer CC, Piccoli L, Kreutmair S, Wertheimer T, Woodhall M, Waters P, Sallusto F, Lanzavecchia A, Mundt S, Becher B, and Schreiner B
- Subjects
- Humans, Receptors, Cholinergic, B-Lymphocytes, Antibodies, Monoclonal, Autoantibodies, Autoantigens, Leukemia, Lymphocytic, Chronic, B-Cell complications, Leukemia, Lymphocytic, Chronic, B-Cell drug therapy, Myasthenia Gravis complications
- Abstract
Background and Objectives: Myasthenia gravis (MG) can in rare cases be an autoimmune phenomenon associated with hematologic malignancies such as chronic lymphocytic leukemia (CLL). It is unclear whether in patients with MG and CLL, the leukemic B cells are the ones directly driving the autoimmune response against neuromuscular endplates., Methods: We identified patients with acetylcholine receptor antibody-positive (AChR
+ ) MG and CLL or monoclonal B-cell lymphocytosis (MBL), a precursor to CLL, and described their clinical features, including treatment responses. We generated recombinant monoclonal antibodies (mAbs) corresponding to the B-cell receptors of the CLL phenotype B cells and screened them for autoantigen binding., Results: A computational immune cell screen revealed a subgroup of 5/38 patients with MG and 0/21 healthy controls who displayed a CLL-like B-cell phenotype. In follow-up hematologic flow cytometry, 2 of these 5 patients were diagnosed with an MBL. An additional patient with AChR+ MG as a complication of manifest CLL presented at our neuromuscular clinic and was successfully treated with the anti-CD20 therapy obinutuzumab plus chlorambucil. We investigated the specificities of expanding CLL-like B-cell clones to assess a direct causal link between the 2 diseases. However, we observed no reactivity of the clones against the AChR, antigens at the neuromuscular junction, or other common autoantigens., Discussion: Our study suggests that AChR autoantibodies are produced by nonmalignant, polyclonal B cells The new anti-CD20 treatment obinutuzumab might be considered in effectively treating AChR+ MG., Classification of Evidence: This is a single case study and provides Class IV evidence that obinutuzumab is safe to use in patients with MG., (Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.)- Published
- 2023
- Full Text
- View/download PDF
41. Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria.
- Author
-
Fadda G, Waters P, Woodhall M, Brown RA, O'Mahony J, Castro DA, Longoni G, Yeh EA, Marrie RA, Arnold DL, Banwell B, and Bar-Or A
- Subjects
- Aquaporin 4, Autoantibodies, Humans, Immunoglobulin G, Myelin-Oligodendrocyte Glycoprotein, Prospective Studies, Multiple Sclerosis diagnostic imaging
- Abstract
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is now recognized as distinct from multiple sclerosis (MS)., Objective: To evaluate the importance of considering myelin oligodendrocyte glycoprotein (MOG)-immunoglobulin-G (IgG) serology when applying MS diagnostic criteria in children., Methods: Within a prospective cohort of children meeting MS criteria (median follow-up = 6 years, interquartile range (IQR) = 4-9), we measured MOG-IgG in serial archived serum obtained from presentation, and compared imaging and clinical features between seropositive and seronegative participants., Results: Of 65 children meeting MS criteria (median age = 14.0 years, IQR = 10.9-15.1), 12 (18%) had MOG-IgG at disease onset. Seropositive participants were younger, had brain magnetic resonance imaging (MRI) features atypical for MS, rarely had cerebrospinal fluid (CSF) oligoclonal bands (2/8, 25%), and accumulated fewer T2 lesions over time. On serial samples, 5/12 (42%) were persistently seropositive, 5/12 (42%) became seronegative, and 2/12 (17%) had fluctuating results. All 12 children experienced a disease course different from typical MS., Conclusion: While children with MOG-IgG can have clinical, CSF, and MRI features conforming to MS criteria, the presence of MOG-IgG is associated with atypical features and predicts a non-MS disease course. Given MOG-IgG seropositivity can wane over time, testing at first attack is of considerable importance for the diagnosis of MOGAD.
- Published
- 2022
- Full Text
- View/download PDF
42. Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.
- Author
-
Damato V, Spagni G, Monte G, Woodhall M, Jacobson L, Falso S, Smith T, Iorio R, Waters P, Irani SR, Vincent A, and Evoli A
- Subjects
- Adult, Autoantibodies, Cohort Studies, Humans, Receptors, Cholinergic, Myasthenia Gravis diagnosis, Receptor Protein-Tyrosine Kinases
- Abstract
Objective: Patients with myasthenia gravis without acetylcholine receptor (AChR) or muscle-specific kinase (MuSK) antibodies detected by radioimmunoprecipitation assays (RIAs) are classified as seronegative myasthenia gravis (SNMG). Live cell-based assays (l-CBAs) can detect additional antibodies to clustered AChR, MuSK and low-density lipoprotein receptor-related protein 4 (LRP4), but positivity rates are variable and both clinical relevance and utility of CBA platforms remain unclear., Methods: Sera from 82 patients with SNMG were tested by l-CBAs. Human embryonic kidney cells were transfected to individually express clustered AChR, MuSK or LRP4; or transfected to jointly express both clustered adult AChR and MuSK. Sera from 30 and 20 patients positive by RIA for AChR or MuSK antibodies were used as comparators., Results: 53 of 82 (72%) patients with SNMG had generalised and 29 (28%) had ocular disease. The clustered AChR CBA detected antibodies in 16 of 82 patients (19.5%; including 4 patients with solely fetal AChR antibodies), while 7 of 82 (8.5%) patients had MuSK antibodies. A novel exploratory combined adult AChR-MuSK l-CBA efficiently detected all these antibodies in a subset of the SNMG cohort. No LRP4 antibodies were identified. Overall, patients with SNMG with clustered AChR antibodies, CBA-positive MuSK-MG or triple seronegative were younger, had less severe disease than patients with RIA-positive MG and had a better clinical outcome when immunotherapy was started soon after disease onset, although the time interval from onset to immunotherapy was not different when compared with patients with RIA-positive MG., Conclusion: Around one-third of patients with SNMG had AChR or MuSK antibodies by l-CBAs, which were efficiently detected with a combined l-CBA. The results in this large and unselected cohort of patients with MG demonstrate the diagnostic usefulness of performing CBAs and the importance of making these tests more widely available., Competing Interests: Competing interests: AV and the University of Oxford held a patent for detection of MuSK antibody assays (expired 2020), licensed to Athena Diagnostics; AV received a proportion of royalties. SRI and PW are co-applicants and receive royalties on patent application WO/2010/046716 entitled ‘Neurological Autoimmune Disorders’ (the patent has been licensed for the development of assays for LGI1 and other VGKC-complex antibodies) and have filed two other patents regarding autoantibody diagnostic algorithms., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
43. Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders.
- Author
-
Damato V, Theorell J, Al-Diwani A, Kienzler AK, Makuch M, Sun B, Handel A, Akdeniz D, Berretta A, Ramanathan S, Fower A, Whittam D, Gibbons E, McGlashan N, Green E, Huda S, Woodhall M, Palace J, Sheerin F, Waters P, Leite MI, Jacob A, and Irani SR
- Subjects
- Autoantibodies, Humans, Lymph Nodes metabolism, Aquaporin 4 drug effects, Aquaporin 4 metabolism, Germinal Center pathology, Immunologic Factors pharmacology, Immunologic Factors therapeutic use, Neuromyelitis Optica drug therapy, Rituximab pharmacology, Rituximab therapeutic use
- Abstract
Neuromyelitis optica spectrum disorders (NMOSDs) are caused by immunoglobulin G (IgG) autoantibodies directed against the water channel aquaporin-4 (AQP4). In NMOSDs, discrete clinical relapses lead to disability and are robustly prevented by the anti-CD20 therapeutic rituximab; however, its mechanism of action in autoantibody-mediated disorders remains poorly understood. We hypothesized that AQP4-IgG production in germinal centers (GCs) was a core feature of NMOSDs and could be terminated by rituximab. To investigate this directly, deep cervical lymph node (dCLN) aspirates (n = 36) and blood (n = 406) were studied in a total of 63 NMOSD patients. Clinical relapses were associated with AQP4-IgM generation or shifts in AQP4-IgG subclasses (odds ratio = 6.0; range of 3.3 to 10.8; P < 0.0001), features consistent with GC activity. From seven dCLN aspirates of patients not administered rituximab, AQP4-IgGs were detected alongside specific intranodal synthesis of AQP4-IgG. AQP4-reactive B cells were isolated from unmutated naive and mutated memory populations in both blood and dCLNs. After rituximab administration, fewer clinical relapses (annual relapse rate of 0.79 to 0; P < 0.001) were accompanied by marked reductions in both AQP4-IgG (fourfold; P = 0.004) and intranodal B cells (430-fold; P < 0.0001) from 11 dCLNs. Our findings implicate ongoing GC activity as a rituximab-sensitive driver of AQP4 antibody production. They may explain rituximab’s clinical efficacy in several autoantibody-mediated diseases and highlight the potential value of direct GC measurements across autoimmune conditions.
- Published
- 2022
- Full Text
- View/download PDF
44. Significance of Neuronal Autoantibodies in Comparison to Infectious Etiologies among Patients Presenting with Encephalitis in a Region with a High Prevalence of Infections.
- Author
-
Chang T, Moloney T, Jacobson L, Malavige N, Lohitharajah J, Wanigasinghe J, Peach S, Woodhall M, Berretta A, Waters P, and Vincent A
- Abstract
Background: Prevalence of antibody-mediated autoimmune encephalitis (AE) is reported to be comparable to infectious encephalitis in Western populations. We evaluated the frequency and significance of AE and neuronal autoantibodies in comparison to infectious etiologies among patients presenting with encephalitis in a South Asian population., Methods: Ninety-nine consecutive patients with a clinical diagnosis of encephalitis/meningoencephalitis admitted to two of the largest tertiary-care hospitals in Sri Lanka were studied. PCR and ELISA were used to screen viruses while Gram stain and culture were used to screen bacteria. Sera were tested for antibodies binding to primary embryonic rat hippocampal neuronal cultures and cell-based assays for antibodies to NMDAR, LGI1, CASPR2, Contactin2, AMPAR, GABA
A R, GABAB R, aquaporin-4 and MOG., Results: Patient ages ranged from 1 month to 73 years (mea n = 24.91; SD = 21.33) with a male: female ratio of 1.75:1. A viral etiology was identified in 27.3% and bacterial meningoencephalitis was diagnosed in 17.1%. Sera of nine patients had antibodies binding to live primary neurons, but only five had specific antibodies to CASPR2 ( n = 1), NMDAR ( n = 2) or GABAB R-antibodies ( n = 2). Moreover, the patients with CASPR2 antibodies and NMDAR-antibodies were also positive for dengue antibodies. Only the two patients with NMDAR-antibodies had features and responses to immunotherapy consistent with AE., Conclusions: Identified infectious forms of meningoencephalitis (44.4%) greatly exceeded the occurrence of neuronal autoantibodies (9.1%) and AE (2%) in Sri Lanka, and this may be common in those regions where infections are prevalent., Competing Interests: There are no conflicts of interest., (Copyright: © 2022 Annals of Indian Academy of Neurology.)- Published
- 2022
- Full Text
- View/download PDF
45. Frequency of MOG-IgG in cerebrospinal fluid versus serum.
- Author
-
Pace S, Orrell M, Woodhall M, Palace J, Leite MI, Irani SR, Waters P, and Handel AE
- Subjects
- Aged, Databases, Factual, Female, Humans, Immunoglobulin G blood, Immunoglobulin G cerebrospinal fluid, Myelitis, Transverse blood, Myelitis, Transverse cerebrospinal fluid, Optic Neuritis blood, Optic Neuritis cerebrospinal fluid, Young Adult, Immunoglobulin G metabolism, Myelin-Oligodendrocyte Glycoprotein immunology, Myelitis, Transverse metabolism, Optic Neuritis metabolism
- Abstract
Competing Interests: Competing interests: PW is a named inventor on patents for antibody assays and has received royalties. He has received honoraria from Biogen Idec, Mereo Biopharma, Retrogenix, UBC, Euroimmun AG and Alexion; travel grants from the Guthy-Jackson Charitable Foundation; and research funding from Euroimmun AG.
- Published
- 2022
- Full Text
- View/download PDF
46. Response to treatment in NMOSD: the Australasian experience.
- Author
-
Clarke L, Bukhari W, O'Gorman CM, Khalilidehkordi E, Arnett S, Woodhall M, Prain KM, Parratt JDE, Barnett MH, Marriott MP, McCombe PA, Sutton I, Boggild M, Brownlee W, Carroll WM, Hodgkinson S, Macdonell RAL, Mason DF, Pereira J, Slee M, Das C, Henderson APD, Kermode AG, Lechner-Scott J, Waters P, Sun J, and Broadley SA
- Subjects
- Aquaporin 4, Humans, Immunosuppressive Agents therapeutic use, Retrospective Studies, Rituximab therapeutic use, Neuromyelitis Optica drug therapy
- Abstract
Background: Neuromyelitis optica spectrum disorder (NMOSD) is associated with significant morbidity and mortality. Several therapies have been recommended for NMOSD and more recently clinical trials have demonstrated efficacy for three monoclonal antibody therapies. We present a retrospective observational study of treatment response in NMOSD., Methods: This was a retrospective, unblinded, observational study of treatment efficacy for rituximab and traditional immunosuppressive therapy in patients with AQP4 antibody positive NMOSD. Treatment efficacy was assessed using annualised relapse rates (ARR), time to first relapse and expanded disability status scale (EDSS) scores., Results: Complete relapse and treatment data were available for 43/68 (63%) of AQP4 antibody positive NMOSD cases covering 74 episodes of treatment. In a time to first relapse analysis rituximab showed a risk ratio of 0.23 (95% CI 0.08 - 0.65) when compared with no treatment and there was a non-significant reduction in ARR of 35% compared to pre-treatment. β-interferon (p = 0.0002) and cyclophosphamide (p = 0.0034) were associated with an increased ARR compared to pre-treatment. Rituximab (median 4.0 [range 0.0 - 7.0]; p = 0.042) and traditional immunosuppressive therapy (median 4.0 [range 0.0 - 8.0]; p = 0.016) were associated with a lower final EDSS compared to β-interferon (median 6.0 [range 4.0 - 7.5])., Conclusions: These data provide additional support for the use of rituximab in preference to traditional immunosuppressive agents and MS disease modifying therapies as first line treatment of NMOSD., (Crown Copyright © 2021. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
47. Utility of Live Cell-Based Assays for Autoimmune Neurology Diagnostics.
- Author
-
Woodhall M, Mgbachi V, Fox H, Irani S, and Waters P
- Subjects
- Humans, Autoantibodies, Neurology
- Published
- 2022
- Full Text
- View/download PDF
48. Predictors of relapse in MOG antibody associated disease: a cohort study.
- Author
-
Huda S, Whittam D, Jackson R, Karthikeayan V, Kelly P, Linaker S, Mutch K, Kneen R, Woodhall M, Murray K, Hunt D, Waters P, and Jacob A
- Subjects
- Cohort Studies, England, Female, Humans, Male, Myelin-Oligodendrocyte Glycoprotein, Northern Ireland, Recurrence, Scotland, Aquaporin 4, Autoantibodies, Demyelinating Autoimmune Diseases, CNS epidemiology
- Abstract
Objective: To identify factors predictive of relapse risk and disability in myelin oligodendrocyte glycoprotein associated disease (MOGAD)., Setting: Patients were seen by the neuromyelitis optica spectrum disorders (NMOSD) service in Liverpool, UK, a national referral centre for adult patients with MOGAD, NMOSD and related conditions., Participants: Patients with MOGAD=76 from England, Northern Ireland and Scotland were included in this cohort study., Results: Relapsing disease was observed in 55% (42/76) of cases. Steroid treatment > 1 month (OR 0.2, 95% CI 0.05 to 0.80; p=0.022), transverse myelitis (TM) at first attack (OR 0.03, 95% CI 0.004 to 0.23; p=0.001) and male sex (OR 0.16, 95% CI 0.04 to 0.68; p=0.014) were associated with monophasic disease (area under the curve=0.85). Male sex (HR 0.46, 95% CI 0.24 to 0.89; p=0.011) and TM at disease onset (HR 0.42, 95% CI 0.22 to 0.82; p=0.011) were also associated with an increased latency to first relapse. 45% (32/71) of patients became MOG-antibody negative and in relapsing patients negative seroconversion was associated with a lower relapse risk (relative risk 0.11 95% CI 0.05 to 0.26; p<0.001). No specific factors were predictive of visual or overall disability., Conclusions: Male patients with spinal cord involvement at disease onset have a lower risk of relapsing disease and longer latency to first relapse. Steroid treatment for at least 1 month at first attack was also associated with a monophasic disease course. MOG-antibody negative seroconversion was associated with a lower risk of relapse and may help inform treatment decisions and duration., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
49. MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
- Author
-
Clarke L, Arnett S, Bukhari W, Khalilidehkordi E, Jimenez Sanchez S, O'Gorman C, Sun J, Prain KM, Woodhall M, Silvestrini R, Bundell CS, Abernethy DA, Bhuta S, Blum S, Boggild M, Boundy K, Brew BJ, Brownlee W, Butzkueven H, Carroll WM, Chen C, Coulthard A, Dale RC, Das C, Fabis-Pedrini MJ, Gillis D, Hawke S, Heard R, Henderson APD, Heshmat S, Hodgkinson S, Kilpatrick TJ, King J, Kneebone C, Kornberg AJ, Lechner-Scott J, Lin MW, Lynch C, Macdonell RAL, Mason DF, McCombe PA, Pereira J, Pollard JD, Ramanathan S, Reddel SW, Shaw CP, Spies JM, Stankovich J, Sutton I, Vucic S, Walsh M, Wong RC, Yiu EM, Barnett MH, Kermode AGK, Marriott MP, Parratt JDE, Slee M, Taylor BV, Willoughby E, Brilot F, Vincent A, Waters P, and Broadley SA
- Abstract
Neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS) are inflammatory diseases of the CNS. Overlap in the clinical and MRI features of NMOSD and MS means that distinguishing these conditions can be difficult. With the aim of evaluating the diagnostic utility of MRI features in distinguishing NMOSD from MS, we have conducted a cross-sectional analysis of imaging data and developed predictive models to distinguish the two conditions. NMOSD and MS MRI lesions were identified and defined through a literature search. Aquaporin-4 (AQP4) antibody positive NMOSD cases and age- and sex-matched MS cases were collected. MRI of orbits, brain and spine were reported by at least two blinded reviewers. MRI brain or spine was available for 166/168 (99%) of cases. Longitudinally extensive (OR = 203), "bright spotty" (OR = 93.8), whole (axial; OR = 57.8) or gadolinium (Gd) enhancing (OR = 28.6) spinal cord lesions, bilateral (OR = 31.3) or Gd-enhancing (OR = 15.4) optic nerve lesions, and nucleus tractus solitarius (OR = 19.2), periaqueductal (OR = 16.8) or hypothalamic (OR = 7.2) brain lesions were associated with NMOSD. Ovoid (OR = 0.029), Dawson's fingers (OR = 0.031), pyramidal corpus callosum (OR = 0.058), periventricular (OR = 0.136), temporal lobe (OR = 0.137) and T1 black holes (OR = 0.154) brain lesions were associated with MS. A score-based algorithm and a decision tree determined by machine learning accurately predicted more than 85% of both diagnoses using first available imaging alone. We have confirmed NMOSD and MS specific MRI features and combined these in predictive models that can accurately identify more than 85% of cases as either AQP4 seropositive NMOSD or MS., Competing Interests: MHB has received research support, speaking engagement honoraria, advisory board honoraria and travel sponsorship from Biogen Idec, Merck, Novartis, Roche and Sanofi-Genzyme, and is a consulting neurologist for RxMx and is Research Director of the Sydney Neuroimaging Analysis Centre. MB has received travel sponsorship and honoraria from Sanofi-Genzyme, Teva, Novartis, Biogen Idec and Roche. BB has received honoraria as a board member for GlaxoSmithKline, Biogen Idec, ViiV Healthcare and Merck Serono, has received speaker honoraria from ViiV Healthcare, Boehringer Ingelheim, Abbott, Abbvie, and Biogen Idec; has received travel sponsorship from Abbott and ViiV Healthcare, and has received research support funding from EI Lilly, GlaxoSmithKline, ViiV Healthcare and Merck Serono. FB has received speaker's honoraria from Biogen-Idec and EMD Serono. SAB has received honoraria for attendance at advisory boards and travel sponsorship from Bayer-Schering, Biogen-Idec, Merck-Serono, Novartis, and Sanofi-Genzyme, has received speakers honoraria from Biogen-Idec and Genzyme, is an investigator in clinical trials sponsored by Biogen Idec, Novartis and Genzyme, and was the recipient of an unencumbered research grant from Biogen-Idec. HB has received honoraria for serving on scientific advisory boards for Biogen Idec, Novartis and Sanofi-Genzyme, has received conference travel sponsorship from Novartis and Biogen Idec, has received honoraria for speaking and acting as Chair at educational events organised by Novartis, Biogen Idec, Medscape and Merck Serono, serves on steering committees for trials conducted by Biogen Idec and Novartis, is chair (honorary) of the MSBase Foundation, which has received research support from Merck Serono, Novartis, Biogen Idec, Genzyme Sanofi and CSL Biopharma and has received research support form Merck Serono. WC has been the recipient of travel sponsorship from, and provided advice to, Bayer Schering Pharma, Biogen-Idec, Novartis, Genzyme, Sanofi-Aventis, BioCSL and Merck-Serono. RD has received research funding from the National Health and Medical Research Council, MS Research Australia, Star Scientific Foundation, Pfizer Neuroscience, Tourette Syndrome Association, University of Sydney, and the Petre Foundation and has received honoraria from Biogen-Idec and Bristol-Myers Squibb as an invited speaker. MF-P has received travel sponsorship from Biogen Australia and New Zealand. RH has received honoraria, educational support and clinic funding from Novartis, Biogen Idec, Genzyme and BioCSL. AGKK has received scientific consulting fees and/or lecture honoraria from Bayer, BioCSL, Biogen-Idec, Genzyme, Lgpharma, Merck, Mitsubishi Tanabe Pharma, NeuroScientific Biopharmaceuticals, Novartis, Roche, Sanofi-Aventis, and Teva. TK has received travel sponsorship from Novartis, BioCSL, Novartis, Merck Serono and Biogen Idec, has received speaker honoraria from Biogen Idec, BioCSL, Merck Serono, Teva, Genzyme and Novartis, has received research support from Biogen Idec, Genzyme, GlaxoSmithKline, Bayer-Schering and Merck Serono, and has received scientific consulting fees from GlaxoSmithKline China, Biogen-Idec and Novartis. JK has received remuneration for advisory board activities and presentations from Bayer Healthcare, Biogen Idec, BioCSL, Genzyme and Novartis. CK has received travel support, honoraria and advisory board payments from Biogen Idec, Bayer, Genzyme, Novartis and Serono. JL-S has received unencumbered funding as well as honoraria for presentations and membership on advisory boards from Sanofi Aventis, Biogen Idec, Bayer Health Care, CSL, Genzyme, Merck Serono, Novartis Australia and Teva. RM has received honoraria for attendance at advisory boards and travel sponsorship from Bayer-Schering, Biogen-Idec, CSL, Merck-Serono, Novartis, and Sanofi-Genzyme. MM has received travel sponsorship, honoraria, trial payments, research and clinical support from Bayer Schering, Biogen Idec, BioCSL, Genzyme, Novartis, and Sanofi Aventis Genzyme. DM has received honoraria for attendance at advisory boards from Biogen-Idec and Novartis, and travel sponsorship from Bayer-Schering, Biogen-Idec, and Sanofi-Genzyme. PM has received honoraria or travel sponsorship from Novartis, Sanofi-Aventis and Biogen Idec. JP has received travel sponsorship, honoraria for presentations and membership on advisory boards from Biogen Idec and Novartis and Sanofi Aventis. JDP has received honoraria for seminars or advisory boards from Teva, Biogen, Sanofi-Genzyme, Novartis, Merck, Bayer and research grants or fellowships from Merck, Novartis, Bayer, Biogen, Sanofi-Genzyme, and Teva. SR has received honoraria for advisory consultancy from UCB and speaker's honoraria from Biogen Idec. SWR has received travel sponsorship, honoraria, trial payments, research and clinical support from Aspreva, Baxter, Bayer Schering, Biogen Idec, BioCSL, Genzyme, Novartis, Sanofi Aventis Genzyme and Servier, and is a director of Medical Safety Systems Pty Ltd. CPS has received travel sponsorship from Biogen Idec, Novartis and Bayer-Schering. IS has received remuneration for Advisory Board activities from Biogen, CSL, and Bayer Schering and educational activities with Biogen, CSL and travel sponsorship from Biogen, Novartis and Bayer Schering. JMS has received honoraria for lectures and participation in advisory boards, and travel sponsorship from Novartis, BioCSL, Genzyme, and Biogen Idec. BT has received travel sponsorship from Novartis and Bayer Schering. AV and the University of Oxford hold patents and receive royalties for antibody testing. PW and the University of Oxford hold patents for antibody assays and have received royalties, has received honoraria from Alexion, Biogen Idec F. Hoffmann-La Roche, Retrogenix, UBC and Euroimmun AG, and travel grants from the Guthy-Jackson Charitable Foundation. EW has received honoraria for participation in advisory boards from Biogen-Idec and Novartis, travel sponsorship from Biogen-Idec, Bayer-Schering and Teva and is an investigator in clinical trials funded by Biogen-Idec and Teva. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Clarke, Arnett, Bukhari, Khalilidehkordi, Jimenez Sanchez, O'Gorman, Sun, Prain, Woodhall, Silvestrini, Bundell, Abernethy, Bhuta, Blum, Boggild, Boundy, Brew, Brownlee, Butzkueven, Carroll, Chen, Coulthard, Dale, Das, Fabis-Pedrini, Gillis, Hawke, Heard, Henderson, Heshmat, Hodgkinson, Kilpatrick, King, Kneebone, Kornberg, Lechner-Scott, Lin, Lynch, Macdonell, Mason, McCombe, Pereira, Pollard, Ramanathan, Reddel, Shaw, Spies, Stankovich, Sutton, Vucic, Walsh, Wong, Yiu, Barnett, Kermode, Marriott, Parratt, Slee, Taylor, Willoughby, Brilot, Vincent, Waters and Broadley.)
- Published
- 2021
- Full Text
- View/download PDF
50. Comparison of N-methyl-D-aspartate receptor antibody assays using live or fixed substrates.
- Author
-
Thouin A, Gastaldi M, Woodhall M, Jacobson L, and Vincent A
- Subjects
- Autoantibodies, Humans, Receptors, N-Methyl-D-Aspartate, Anti-N-Methyl-D-Aspartate Receptor Encephalitis diagnosis
- Abstract
The diagnostic criteria for N-methyl-D-aspartate receptor antibody (NMDAR-Ab) encephalitis require the presence of CSF antibodies against the NMDAR, whereas serum antibodies are considered specific only if accompanied by CSF antibodies. Current assays include in-house immunochemistry (IHC), or cell-based assays (CBA) which use live (L-CBA) or fixed cells (F-CBA), and commercially available fixed-cells CBA (C-CBA), but these have not been compared in parallel. We compared the L-CBA with F-CBA, C-CBA, and IHC using sera and CSFs archived from > 30,000 received for testing and previously positive by L-CBA. Referring neurologists, if identified, provided "definite" or "unlikely" diagnoses of NMDAR-Ab encephalitis for 31 paired serum-CSF samples and 53 unpaired sera. There was good concordance between paired sera and CSFs, with 13/16 "definite" pairs positive, and 7/8 "unlikely" pairs negative in all in-house assays. In unpaired "definite" sera, L-CBA was most sensitive. However, 19/24 serum samples from "unlikely" patients were positive by L-CBA, with only 5/24 and 1/24 positive by F-CBA and IHC, respectively. In available samples, C-CBA demonstrated high sensitivity for CSF, but surprisingly low sensitivity for serum. Overall, regardless of the technique, CSF results were accurate and easy to interpret, but if CSF is unavailable, negative serum C-CBA results in cases with suspected NMDAR-Ab encephalitis could be repeated by a more sensitive in-house assay. Although these assays are sensitive, particularly for CSF, referral of sera with low pre-test probability should be avoided to reduce clinically-irrelevant "false positive" results.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.